BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1085 related articles for article (PubMed ID: 29311644)

  • 1. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
    Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
    Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease.
    Park YM; Ha E; Gu KN; Shin GY; Lee CK; Kim K; Kim HJ
    Clin Transl Gastroenterol; 2020 Jul; 11(7):e00213. PubMed ID: 32764209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
    Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
    Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overrepresentation of Enterobacteriaceae and
    Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
    Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
    Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
    Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
    Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
    Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microbial signature for Crohn's disease.
    Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
    Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic modelling reveals broad changes in gut microbial metabolism in inflammatory bowel disease patients with dysbiosis.
    Heinken A; Hertel J; Thiele I
    NPJ Syst Biol Appl; 2021 May; 7(1):19. PubMed ID: 33958598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome.
    Bolte LA; Vich Vila A; Imhann F; Collij V; Gacesa R; Peters V; Wijmenga C; Kurilshikov A; Campmans-Kuijpers MJE; Fu J; Dijkstra G; Zhernakova A; Weersma RK
    Gut; 2021 Jul; 70(7):1287-1298. PubMed ID: 33811041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
    Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
    J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.